AbbVie Inc.
ABBV
$214.50
$2.201.04%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -9.72% | 5.34% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -9.72% | 5.34% | |||
| Cost of Revenue | -7.34% | 2.13% | |||
| Gross Profit | -10.62% | 6.60% | |||
| SG&A Expenses | -8.67% | 11.41% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.05% | 7.61% | |||
| Operating Income | -14.89% | 1.21% | |||
| Income Before Tax | -61.06% | 273.67% | |||
| Income Tax Expenses | -59.91% | 62.17% | |||
| Earnings from Continuing Operations | -61.60% | 865.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -300.00% | 150.00% | |||
| Net Income | -61.73% | 876.34% | |||
| EBIT | -14.89% | 1.21% | |||
| EBITDA | -11.69% | -0.10% | |||
| EPS Basic | -61.98% | 923.12% | |||
| Normalized Basic EPS | -18.49% | 0.01% | |||
| EPS Diluted | -61.98% | 923.12% | |||
| Normalized Diluted EPS | -18.67% | 0.18% | |||
| Average Basic Shares Outstanding | -0.23% | 0.28% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.11% | |||
| Dividend Per Share | 0.00% | 5.49% | |||
| Payout Ratio | 1.77% | -0.90% | |||